Botanical species · safety record

Hyoscyamus albus

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 adverse-effect records for Hyoscyamus albus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hyoscyamus albus L.

4Constituent measurements
2Safety records
3Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids1
  • Saponins1
  • Tannins1
  • Tropane alkaloids1

Plant parts

  • Leaves4
  • Aerial part of plants1
  • Live plants1

Preparations

  • Solvent extraction5
  • Thermal treatment (heating for preservation)1

Effect types

  • Nephrotoxicity1
  • Neurotoxicity1

Target tissues

  • Neurologic1
  • Urogenital: kidneys1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
SaponinsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
TanninsLeavesSolvent extractionPhytochemical screeningNo resolvable identifier
Tropane alkaloidsLive plantsSolvent extractionGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NephrotoxicityUrogenital: kidneysLeavesSolvent extractionRat (as animal)Acute toxicityNo resolvable identifier
NeurotoxicityNeurologicAerial part of plantsThermal treatment (heating for preservation)Human (as organism)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Benhouda, A., Yahia, M. Toxicity, analgesic and anti-pyretic activities of methanolic extract from hyoscyamus albus' leaves in albinos rats. International journal of pharmacy and pharmaceutical sciences, 2014, vol. 6, no. 3, p. 121-127.
  2. Paravisiliu, Marie., Constantellos, B. Food intoxication by white henbane. Annales pharmaceutiques francaises, 1947, p. 109-111.
  3. DOERKSCHMITZ, K., WITTE, L., ALFERMANN, AW. TROPANE ALKALOID PATTERNS IN PLANTS AND HAIRY ROOTS OF HYOSCYAMUS-ALBUS. Phytochemistry, 1994, vol. 35, no. 1, p. 107-110.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue